1. Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial. Issue 2 (4th November 2022) Authors: Rugo, Hope S.; Im, Seock-Ah; Cardoso, Fatima; Cortes, Javier; Curigliano, Giuseppe; Musolino, Antonino; Pegram, Mark D.; Bachelot, Thomas; Wright, Gail S.; Saura, Cristina; Escrivá-de-Romaní, Santiago; De Laurentiis, Michelino; Schwartz, Gary N.; Pluard, Timothy J.; Ricci, Francesco; Gwin, Willia... Journal: Journal of clinical oncology Issue: Volume 41:Issue 2(2023) Page Start: 198 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗